Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant

Adjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fish & shellfish immunology 2015-07, Vol.45 (1), p.157-166
Hauptverfasser: Rivas-Aravena, Andrea, Fuentes, Yazmin, Cartagena, Julio, Brito, Tania, Poggio, Verónica, La Torre, José, Mendoza, Hegaly, Gonzalez-Nilo, Fernando, Sandino, Ana María, Spencer, Eugenio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 166
container_issue 1
container_start_page 157
container_title Fish & shellfish immunology
container_volume 45
creator Rivas-Aravena, Andrea
Fuentes, Yazmin
Cartagena, Julio
Brito, Tania
Poggio, Verónica
La Torre, José
Mendoza, Hegaly
Gonzalez-Nilo, Fernando
Sandino, Ana María
Spencer, Eugenio
description Adjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of a vaccine against ISAV. The Ad and an inactivated ISAV (V) were loaded in chitosan nanoparticles (NPs) to be administered orally to Atlantic salmon. NP-Ad was able to deliver the DNA ex vivo and in vivo. Oral administration of the NPs stimulated the expression of immune molecules, but did not stimulate the humoral response. Although the vaccination with NP-V results in a modest protection of fish against ISAV, NP-V administered together with NP-Ad caused a protection of 77%. Therefore, the DNA coding for the replicase of alphavirus could be administered orally and can potentiate the immuneprotection of a virine against infection. •Nanoparticles of chitosan with a virine of ISAV and the replicon of SAV administered orally, protected Atlantic salmon against ISAV.•Replicon of SAV strengthened the protection provided by a virine of ISAV in Atlantic salmon.•Replicon of salmon alphavirus strengthened the antiviral immune response triggered by the vaccine.
doi_str_mv 10.1016/j.fsi.2015.03.033
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1732825461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1050464815001424</els_id><sourcerecordid>1682208203</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-22e79a7d8e9d7ea0a2412d37ff47deacd6c6b9beafac398738d58ad150f073f63</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0Eou3CD-CCfOSSxR-JnYjTqgVaqRIHPq7WrD0uXiVxsJNI8OtxtIUjSCPNaPS8rzTzEvKKsz1nXL097X0Oe8F4s2eylHxCLjnrmqrrav10mxtW1apuL8hVzifGmJKKPScXommVYFpckl83uGIfpwHHmUZPgY4wxgnSHGyP1REyOhoT9HQFa8OI1MdED3MPYyFohn6II4UHCGOe6d3nwze65DA-UCjbfvoOa0hLpgmnPtiNzBTcaVmL_AV55qHP-PKx78jXD--_XN9W958-3l0f7itbd91cCYG6A-1a7JxGYCBqLpzU3tfaIVinrDp2RwQPVnatlq1rWnC8YZ5p6ZXckTdn3ynFHwvm2QwhW-zLCRiXbLiWohVNrfj_UdUKwVpRXr0j_IzaFHNO6M2UwgDpp-HMbOmYkynpmC0dw2SpTfP60X45Duj-Kv7EUYB3ZwDLP9aAyWQbcLToQkI7GxfDP-x_Ay9koZ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1682208203</pqid></control><display><type>article</type><title>Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rivas-Aravena, Andrea ; Fuentes, Yazmin ; Cartagena, Julio ; Brito, Tania ; Poggio, Verónica ; La Torre, José ; Mendoza, Hegaly ; Gonzalez-Nilo, Fernando ; Sandino, Ana María ; Spencer, Eugenio</creator><creatorcontrib>Rivas-Aravena, Andrea ; Fuentes, Yazmin ; Cartagena, Julio ; Brito, Tania ; Poggio, Verónica ; La Torre, José ; Mendoza, Hegaly ; Gonzalez-Nilo, Fernando ; Sandino, Ana María ; Spencer, Eugenio</creatorcontrib><description>Adjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of a vaccine against ISAV. The Ad and an inactivated ISAV (V) were loaded in chitosan nanoparticles (NPs) to be administered orally to Atlantic salmon. NP-Ad was able to deliver the DNA ex vivo and in vivo. Oral administration of the NPs stimulated the expression of immune molecules, but did not stimulate the humoral response. Although the vaccination with NP-V results in a modest protection of fish against ISAV, NP-V administered together with NP-Ad caused a protection of 77%. Therefore, the DNA coding for the replicase of alphavirus could be administered orally and can potentiate the immuneprotection of a virine against infection. •Nanoparticles of chitosan with a virine of ISAV and the replicon of SAV administered orally, protected Atlantic salmon against ISAV.•Replicon of SAV strengthened the protection provided by a virine of ISAV in Atlantic salmon.•Replicon of salmon alphavirus strengthened the antiviral immune response triggered by the vaccine.</description><identifier>ISSN: 1050-4648</identifier><identifier>EISSN: 1095-9947</identifier><identifier>DOI: 10.1016/j.fsi.2015.03.033</identifier><identifier>PMID: 25862072</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adjuvant ; Adjuvants, Immunologic - administration &amp; dosage ; Adjuvants, Immunologic - pharmacology ; Administration, Oral ; Alphavirus ; Alphavirus - genetics ; Alphavirus - immunology ; Animals ; Atlantic salmon ; Fish Diseases - prevention &amp; control ; Fish Diseases - virology ; Infectious salmon anemia virus ; ISAV ; Isavirus - immunology ; Marine ; Nanoparticles ; Nanoparticles - chemistry ; Orthomyxoviridae Infections - prevention &amp; control ; Orthomyxoviridae Infections - veterinary ; Orthomyxoviridae Infections - virology ; Replicon ; Salmo salar ; Salmon alphavirus ; Togaviridae ; Vaccine ; Vaccines, Inactivated - immunology ; Viral Vaccines - pharmacology</subject><ispartof>Fish &amp; shellfish immunology, 2015-07, Vol.45 (1), p.157-166</ispartof><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-22e79a7d8e9d7ea0a2412d37ff47deacd6c6b9beafac398738d58ad150f073f63</citedby><cites>FETCH-LOGICAL-c499t-22e79a7d8e9d7ea0a2412d37ff47deacd6c6b9beafac398738d58ad150f073f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1050464815001424$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25862072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivas-Aravena, Andrea</creatorcontrib><creatorcontrib>Fuentes, Yazmin</creatorcontrib><creatorcontrib>Cartagena, Julio</creatorcontrib><creatorcontrib>Brito, Tania</creatorcontrib><creatorcontrib>Poggio, Verónica</creatorcontrib><creatorcontrib>La Torre, José</creatorcontrib><creatorcontrib>Mendoza, Hegaly</creatorcontrib><creatorcontrib>Gonzalez-Nilo, Fernando</creatorcontrib><creatorcontrib>Sandino, Ana María</creatorcontrib><creatorcontrib>Spencer, Eugenio</creatorcontrib><title>Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant</title><title>Fish &amp; shellfish immunology</title><addtitle>Fish Shellfish Immunol</addtitle><description>Adjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of a vaccine against ISAV. The Ad and an inactivated ISAV (V) were loaded in chitosan nanoparticles (NPs) to be administered orally to Atlantic salmon. NP-Ad was able to deliver the DNA ex vivo and in vivo. Oral administration of the NPs stimulated the expression of immune molecules, but did not stimulate the humoral response. Although the vaccination with NP-V results in a modest protection of fish against ISAV, NP-V administered together with NP-Ad caused a protection of 77%. Therefore, the DNA coding for the replicase of alphavirus could be administered orally and can potentiate the immuneprotection of a virine against infection. •Nanoparticles of chitosan with a virine of ISAV and the replicon of SAV administered orally, protected Atlantic salmon against ISAV.•Replicon of SAV strengthened the protection provided by a virine of ISAV in Atlantic salmon.•Replicon of salmon alphavirus strengthened the antiviral immune response triggered by the vaccine.</description><subject>Adjuvant</subject><subject>Adjuvants, Immunologic - administration &amp; dosage</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Administration, Oral</subject><subject>Alphavirus</subject><subject>Alphavirus - genetics</subject><subject>Alphavirus - immunology</subject><subject>Animals</subject><subject>Atlantic salmon</subject><subject>Fish Diseases - prevention &amp; control</subject><subject>Fish Diseases - virology</subject><subject>Infectious salmon anemia virus</subject><subject>ISAV</subject><subject>Isavirus - immunology</subject><subject>Marine</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Orthomyxoviridae Infections - veterinary</subject><subject>Orthomyxoviridae Infections - virology</subject><subject>Replicon</subject><subject>Salmo salar</subject><subject>Salmon alphavirus</subject><subject>Togaviridae</subject><subject>Vaccine</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Viral Vaccines - pharmacology</subject><issn>1050-4648</issn><issn>1095-9947</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0Eou3CD-CCfOSSxR-JnYjTqgVaqRIHPq7WrD0uXiVxsJNI8OtxtIUjSCPNaPS8rzTzEvKKsz1nXL097X0Oe8F4s2eylHxCLjnrmqrrav10mxtW1apuL8hVzifGmJKKPScXommVYFpckl83uGIfpwHHmUZPgY4wxgnSHGyP1REyOhoT9HQFa8OI1MdED3MPYyFohn6II4UHCGOe6d3nwze65DA-UCjbfvoOa0hLpgmnPtiNzBTcaVmL_AV55qHP-PKx78jXD--_XN9W958-3l0f7itbd91cCYG6A-1a7JxGYCBqLpzU3tfaIVinrDp2RwQPVnatlq1rWnC8YZ5p6ZXckTdn3ynFHwvm2QwhW-zLCRiXbLiWohVNrfj_UdUKwVpRXr0j_IzaFHNO6M2UwgDpp-HMbOmYkynpmC0dw2SpTfP60X45Duj-Kv7EUYB3ZwDLP9aAyWQbcLToQkI7GxfDP-x_Ay9koZ4</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Rivas-Aravena, Andrea</creator><creator>Fuentes, Yazmin</creator><creator>Cartagena, Julio</creator><creator>Brito, Tania</creator><creator>Poggio, Verónica</creator><creator>La Torre, José</creator><creator>Mendoza, Hegaly</creator><creator>Gonzalez-Nilo, Fernando</creator><creator>Sandino, Ana María</creator><creator>Spencer, Eugenio</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>F1W</scope><scope>FR3</scope><scope>H94</scope><scope>H95</scope><scope>H98</scope><scope>H99</scope><scope>L.F</scope><scope>L.G</scope><scope>P64</scope></search><sort><creationdate>20150701</creationdate><title>Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant</title><author>Rivas-Aravena, Andrea ; Fuentes, Yazmin ; Cartagena, Julio ; Brito, Tania ; Poggio, Verónica ; La Torre, José ; Mendoza, Hegaly ; Gonzalez-Nilo, Fernando ; Sandino, Ana María ; Spencer, Eugenio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-22e79a7d8e9d7ea0a2412d37ff47deacd6c6b9beafac398738d58ad150f073f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adjuvant</topic><topic>Adjuvants, Immunologic - administration &amp; dosage</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Administration, Oral</topic><topic>Alphavirus</topic><topic>Alphavirus - genetics</topic><topic>Alphavirus - immunology</topic><topic>Animals</topic><topic>Atlantic salmon</topic><topic>Fish Diseases - prevention &amp; control</topic><topic>Fish Diseases - virology</topic><topic>Infectious salmon anemia virus</topic><topic>ISAV</topic><topic>Isavirus - immunology</topic><topic>Marine</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Orthomyxoviridae Infections - veterinary</topic><topic>Orthomyxoviridae Infections - virology</topic><topic>Replicon</topic><topic>Salmo salar</topic><topic>Salmon alphavirus</topic><topic>Togaviridae</topic><topic>Vaccine</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Viral Vaccines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivas-Aravena, Andrea</creatorcontrib><creatorcontrib>Fuentes, Yazmin</creatorcontrib><creatorcontrib>Cartagena, Julio</creatorcontrib><creatorcontrib>Brito, Tania</creatorcontrib><creatorcontrib>Poggio, Verónica</creatorcontrib><creatorcontrib>La Torre, José</creatorcontrib><creatorcontrib>Mendoza, Hegaly</creatorcontrib><creatorcontrib>Gonzalez-Nilo, Fernando</creatorcontrib><creatorcontrib>Sandino, Ana María</creatorcontrib><creatorcontrib>Spencer, Eugenio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Aquaculture Abstracts</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Fish &amp; shellfish immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivas-Aravena, Andrea</au><au>Fuentes, Yazmin</au><au>Cartagena, Julio</au><au>Brito, Tania</au><au>Poggio, Verónica</au><au>La Torre, José</au><au>Mendoza, Hegaly</au><au>Gonzalez-Nilo, Fernando</au><au>Sandino, Ana María</au><au>Spencer, Eugenio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant</atitle><jtitle>Fish &amp; shellfish immunology</jtitle><addtitle>Fish Shellfish Immunol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>45</volume><issue>1</issue><spage>157</spage><epage>166</epage><pages>157-166</pages><issn>1050-4648</issn><eissn>1095-9947</eissn><abstract>Adjuvants used in vaccine aquaculture are frequently harmful for the fish, causing melanosis, granulomas and kidney damage. Along with that, vaccines are mostly administered by injection, causing pain and stress to the fish. We used the DNA coding for the replicase of alphavirus as adjuvant (Ad) of a vaccine against ISAV. The Ad and an inactivated ISAV (V) were loaded in chitosan nanoparticles (NPs) to be administered orally to Atlantic salmon. NP-Ad was able to deliver the DNA ex vivo and in vivo. Oral administration of the NPs stimulated the expression of immune molecules, but did not stimulate the humoral response. Although the vaccination with NP-V results in a modest protection of fish against ISAV, NP-V administered together with NP-Ad caused a protection of 77%. Therefore, the DNA coding for the replicase of alphavirus could be administered orally and can potentiate the immuneprotection of a virine against infection. •Nanoparticles of chitosan with a virine of ISAV and the replicon of SAV administered orally, protected Atlantic salmon against ISAV.•Replicon of SAV strengthened the protection provided by a virine of ISAV in Atlantic salmon.•Replicon of salmon alphavirus strengthened the antiviral immune response triggered by the vaccine.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25862072</pmid><doi>10.1016/j.fsi.2015.03.033</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1050-4648
ispartof Fish & shellfish immunology, 2015-07, Vol.45 (1), p.157-166
issn 1050-4648
1095-9947
language eng
recordid cdi_proquest_miscellaneous_1732825461
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adjuvant
Adjuvants, Immunologic - administration & dosage
Adjuvants, Immunologic - pharmacology
Administration, Oral
Alphavirus
Alphavirus - genetics
Alphavirus - immunology
Animals
Atlantic salmon
Fish Diseases - prevention & control
Fish Diseases - virology
Infectious salmon anemia virus
ISAV
Isavirus - immunology
Marine
Nanoparticles
Nanoparticles - chemistry
Orthomyxoviridae Infections - prevention & control
Orthomyxoviridae Infections - veterinary
Orthomyxoviridae Infections - virology
Replicon
Salmo salar
Salmon alphavirus
Togaviridae
Vaccine
Vaccines, Inactivated - immunology
Viral Vaccines - pharmacology
title Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T14%3A17%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20nanoparticle-based%20oral%20vaccine%20for%20Atlantic%20salmon%20against%20ISAV%20using%20an%20alphavirus%20replicon%20as%20adjuvant&rft.jtitle=Fish%20&%20shellfish%20immunology&rft.au=Rivas-Aravena,%20Andrea&rft.date=2015-07-01&rft.volume=45&rft.issue=1&rft.spage=157&rft.epage=166&rft.pages=157-166&rft.issn=1050-4648&rft.eissn=1095-9947&rft_id=info:doi/10.1016/j.fsi.2015.03.033&rft_dat=%3Cproquest_cross%3E1682208203%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1682208203&rft_id=info:pmid/25862072&rft_els_id=S1050464815001424&rfr_iscdi=true